Agentix Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Agentix has been growing earnings at an average annual rate of 8.5%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been declining at an average rate of 91.2% per year.
Información clave
8.5%
Tasa de crecimiento de los beneficios
14.1%
Tasa de crecimiento del BPA
| Crecimiento de la industria Pharmaceuticals | 6.0% |
| Tasa de crecimiento de los ingresos | -91.2% |
| Rentabilidad financiera | n/a |
| Margen neto | n/a |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
No hay actualizaciones
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Agentix. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 0 | 0 | 0 | 0 |
| 31 Mar 24 | 0 | -1 | 1 | 0 |
| 31 Dec 23 | 0 | -1 | 1 | 0 |
| 30 Sep 23 | 0 | -1 | 1 | 1 |
| 30 Jun 23 | 0 | -2 | 1 | 1 |
| 31 Mar 23 | 0 | -1 | 1 | 1 |
| 31 Dec 22 | 0 | -3 | 2 | 1 |
| 30 Sep 22 | 0 | -3 | 2 | 0 |
| 30 Jun 22 | 0 | -3 | 2 | 0 |
| 31 Mar 22 | 0 | -3 | 2 | 0 |
| 28 Feb 22 | 0 | -3 | 2 | 0 |
| 30 Nov 21 | 0 | -1 | 1 | 0 |
| 31 Aug 21 | 0 | -1 | 1 | 0 |
| 31 May 21 | 0 | -1 | 0 | 0 |
| 31 Mar 21 | 0 | -2 | 1 | 0 |
Ingresos de calidad: AGTX is currently unprofitable.
Margen de beneficios creciente: AGTX is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: AGTX is unprofitable, but has reduced losses over the past 5 years at a rate of 8.5% per year.
Acelerando crecimiento: Unable to compare AGTX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: AGTX is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.4%).
Rentabilidad financiera
Alta ROE: AGTX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.